HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xin Xiong Selected Research

Xin Xiong Research Topics

Disease

18Neoplasms (Cancer)
03/2024 - 01/2016
10Inflammation (Inflammations)
01/2023 - 04/2015
4Stroke (Strokes)
01/2023 - 05/2014
4Hepatocellular Carcinoma (Hepatoma)
01/2022 - 07/2013
4Fibrosis (Cirrhosis)
01/2021 - 04/2015
3Myocardial Infarction
01/2024 - 02/2015
3Heart Failure
01/2023 - 01/2012
3Gastroesophageal Reflux (GERD)
12/2022 - 08/2021
3Ulcerative Colitis
01/2022 - 09/2019
3Hypertrophy
10/2021 - 01/2020
3Ischemic Stroke
06/2018 - 08/2010
2Malocclusion (Crossbite)
08/2023 - 01/2021
2Breast Neoplasms (Breast Cancer)
06/2023 - 07/2017
2COVID-19
01/2023 - 03/2021
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2022 - 08/2019
2Cerebral Hemorrhage
03/2022 - 01/2021
2Neoplasm Metastasis (Metastasis)
01/2022 - 08/2021
2Chronic Renal Insufficiency
10/2021 - 05/2021
2Stomach Neoplasms (Stomach Cancer)
01/2021 - 12/2011
2Osteoporosis
01/2021 - 12/2012
2Glioma (Gliomas)
01/2020 - 08/2019
2Prostatic Neoplasms (Prostate Cancer)
07/2019 - 01/2019
2Cognitive Dysfunction
01/2019 - 01/2017
2Coronary Artery Disease (Coronary Atherosclerosis)
12/2014 - 08/2010
1Pediatric Obesity
04/2024
1Adenocarcinoma of Lung
02/2024
1Acute Kidney Injury (Acute Renal Failure)
01/2024
1Acute-Phase Reaction
01/2024
1Kidney Diseases (Kidney Disease)
12/2023
1Diabetic Nephropathies (Diabetic Nephropathy)
12/2023
1Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
12/2023
1Immune System Diseases (Immune Disorders)
09/2023
1Osteoarthritis
06/2023
1AIDS-Related Complex (ARC)
01/2023
1Pain (Aches)
01/2023
1Lung Injury
01/2023
1Diabetic Cardiomyopathies
01/2023
1Cytokine Release Syndrome
01/2023
1Myocarditis (Carditis)
01/2023
1Leukemia
12/2022
1Melanoma (Melanoma, Malignant)
11/2022
1Fatigue
04/2022
1Hyperglycemia
03/2022
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2022

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
01/2024 - 01/2012
8Biomarkers (Surrogate Marker)IBA
02/2024 - 01/2021
5RNA (Ribonucleic Acid)IBA
02/2024 - 06/2015
5CollagenIBA
10/2021 - 07/2019
3MicroRNAs (MicroRNA)IBA
02/2024 - 08/2017
3CytokinesIBA
09/2023 - 04/2015
3Messenger RNA (mRNA)IBA
01/2021 - 01/2016
2salicylhydroxamic acid (SHAM)IBA
01/2024 - 01/2022
2Complement System Proteins (Complement)IBA
01/2024 - 12/2014
2LipidsIBA
12/2023 - 01/2020
2InflammasomesIBA
01/2023 - 04/2015
2AntigensIBA
11/2022 - 01/2022
2AcidsIBA
04/2022 - 10/2019
2Glucose (Dextrose)FDA LinkGeneric
03/2022 - 01/2018
2fuzi drug herbalIBA
01/2022 - 10/2020
2Phosphotransferases (Kinase)IBA
01/2022 - 11/2017
2IndicanIBA
10/2021 - 05/2021
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2015 - 01/2015
2Interleukin-33IBA
02/2015 - 01/2015
116S Ribosomal RNAIBA
04/2024
1Ribosomal DNA (rDNA)IBA
04/2024
12-aminopyrazineIBA
03/2024
1Antineoplastic Agents (Antineoplastics)IBA
03/2024
1Adrenergic Receptors (Adrenergic Receptor)IBA
01/2024
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2024
1purineIBA
01/2024
1IronIBA
01/2024
1Scavenger Receptors (Scavenger Receptor)IBA
12/2023
1Fatty Acids (Saturated Fatty Acids)IBA
12/2023
1Liver X ReceptorsIBA
12/2023
1PlasticsIBA
01/2023
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
01/2023
1ChemokinesIBA
01/2023
1Annexin A2 (Annexin II)IBA
01/2023
1Interleukin-17 (Interleukin 17)IBA
01/2023
1Daunorubicin (Cerubidine)FDA LinkGeneric
12/2022
1Cytarabine (Cytosar-U)FDA LinkGeneric
12/2022
1ArtesunateIBA
12/2022
1peptide AIBA
11/2022
1Peptides (Polypeptides)IBA
11/2022
1Cancer VaccinesIBA
11/2022
1Composite ResinsIBA
04/2022
1Carbon Fiber (Grafil)IBA
04/2022
1ElementsIBA
04/2022
1Pepsin A (Pepsin)IBA
04/2022
1Collagenases (Collagenase)FDA Link
03/2022
1Erlotinib Hydrochloride (CP 358,774)FDA Link
02/2022
1Tyrosine Kinase InhibitorsIBA
02/2022
1icotinibIBA
02/2022
1AfatinibIBA
02/2022

Therapy/Procedure

7Therapeutics
01/2023 - 07/2013
3Dental Occlusion
08/2023 - 01/2023
2Chinese Traditional Medicine (Traditional Chinese Medicine)
04/2021 - 01/2021
1Vertical Dimension (Occlusion Vertical Dimension)
08/2023
1Electroacupuncture
01/2023
1Radiofrequency Therapy
12/2022